Funding round
Mirador Series A
Mirador, which works in precision medicine development in San Diego, raised $400M in a Series A round announced on 21 Mar 2024, led by ARCH Venture Partners. 17 firms took part. It is Mirador's first venture round on record.
$400M
Amount raised
Not disclosed
Post-money valuation
17
Investors
1 lead
Valuation
What this round says about the price
Mirador did not disclose a valuation in this round. It is Mirador's first venture round on record, in the year it was founded (2024). It is 62% of the $650M Mirador has raised in the venture rounds on record. Mirador raised again 18 months later: a Series B round of $250M in Sep 2025.
Mirador's funding rounds
Mirador has 2 venture rounds on record. This one is highlighted.
- Series A this round 21 Mar 2024, led by ARCH Venture Partners $400M
- Series B 30 Sep 2025, led by T. Rowe Price Investment Management, Inc. and Fidelity Management & Research Company $250M
Investors
Who put money in
ARCH Venture Partners led the round with 16 other firms.
Lead investor
- ARCH Venture Partners backs 99 venture-backed companies new investor
Also in the round
- backs 93 venture-backed companies new investor
- Sanofi new investor
- new investor
- Fidelity new investor
- Point72 Ventures backs 72 venture-backed companies new investor
- backs 15 venture-backed companies new investor
- backs 16 venture-backed companies new investor
- backs 19 venture-backed companies new investor
- Invus backs 83 venture-backed companies new investor
- backs 16 venture-backed companies new investor
- Moore Strategic Ventures new investor
- Blue Owl Capital backs 36 venture-backed companies new investor
- backs 18 venture-backed companies new investor
- Venrock backs 93 venture-backed companies new investor
- backs 17 venture-backed companies new investor
- Alexandria Venture Investments new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
178 Series A rounds in Biotechnology within a year either side disclosed an amount; the median was $30M, and this round was 13 times the median. The closest in time, other companies' Series A rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 26 Mar 2024 | $150M | not disclosed | New Enterprise Associates and Deep Track Capital |
| Biotechnology | 20 Mar 2024 | $150M | not disclosed | Catalio Capital Management and Third Rock Ventures |
| Biotechnology | 25 Mar 2024 | $20M | not disclosed | Alta Partners |
| Biotechnology | 1 Mar 2024 | $541K | not disclosed | not named |
| Biotechnology | 3 Apr 2024 | $128M | not disclosed | BVF Partners and Atlas Venture |
| Biotechnology | 15 Feb 2024 | $94M | not disclosed | Versant Ventures and MPM BioImpact |
| Biotechnology | 29 Feb 2024 | $82M | not disclosed | Alaska Permanent Fund Corporation and Cure Ventures |
| Biotechnology | 27 Feb 2024 | $51M | not disclosed | Pfizer Ventures and Epidarex |
Sources
Where this comes from
Reported by 4 sources.
Questions
Frequently asked
How much did Mirador raise in its Series A round?
Mirador raised $400M in its Series A round, announced in Mar 2024.
Who led Mirador's Series A round?
ARCH Venture Partners led it, with OrbiMed, Sanofi, Fairmount Partners, Fidelity and Point72 Ventures and 11 more.
What was Mirador's valuation at the Series A round?
It was not disclosed.
How does it compare with other Series A rounds in Biotechnology?
178 Series A rounds in Biotechnology within a year either side disclosed an amount; the median was $30M, and this round was 13 times the median.
Did Mirador raise again after this round?
Yes: a Series B round in Sep 2025 of $250M.